Clinical Research Management Briefing – March 26, 2018
The National Institutes of Health "All of Us" research program’s goal of sequencing the genomes of one million Americans is proving to be expensive, ambitious and time consuming.
The New York Times, March 19
Next month, the Food and Drug Administration will review eligibility requirements for clinical trials as well as the impact clinical trials have on patient ability to access drugs.
Duluth News Tribune, March 20
Ideally, participants in clinical trials should reflect the community where the drugs are tested. In reality, it’s rare.
St. Louis Post-Dispatch, March 17
The potential benefits of using digital devices to capture physiological and behavioral data include boosting clinical trial recruitment, but ethical questions of how data are collected, stored and secured present barriers.
MM&M, March 13
Blockchain offers an opportunity for patients to easily and securely share health data – hopefully leading to more data being collected and studied for medical advances.
Nature, March 9
Combining new technology with scientific expertise is resulting in better compliance, data and efficiency in clinical research.
FierceBiotech, March 19
Companies are working to use medical data more efficiently to decrease the number of clinical trials and capital needed to bring a drug to market.
Fortune, March 20Contact Us